Allegheny Research Institute (Melanoma/NSCLC) — Pittsburgh, Pennsylvania

Allegheny Research Institute (Melanoma/NSCLC) is a clinical research site located in Pittsburgh, Pennsylvania, United States 15224.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Allegheny Research Institute (Melanoma/NSCLC) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Tumor Skin, Metastatic Melanoma, Melanoma.

Sponsors: Obsidian Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Allegheny Research Institute (Melanoma/NSCLC)?

Allegheny Research Institute (Melanoma/NSCLC) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Allegheny Research Institute (Melanoma/NSCLC) conducted?

Allegheny Research Institute (Melanoma/NSCLC) has 1 clinical trials on record, with 1 currently active. Their work covers Tumor Skin, Metastatic Melanoma, Melanoma.

Is Allegheny Research Institute (Melanoma/NSCLC) accredited by Crixeo Health?

Allegheny Research Institute (Melanoma/NSCLC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Allegheny Research Institute (Melanoma/NSCLC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.